罕见病药物氨己烯酸片怎么吃
(Vigabatrin) is a drug used to treat epilepsy and infantile spasms that was developed in the 1980s. In 1989, vigabatrin was approved for treatment in the UK. On August 21, 2009, the US FDA approved vigabatrin tablets (vigabatrin) as monotherapy for pediatric patients 1 month to 2 years old, where the potential benefits of infantile spasms outweigh the potential risk of vision loss, and as an adjuvant (additional) treatment (CPS) for adult patients with refractory complex partial epilepsy.
How to take the rare disease drug vigabatrin tablets?
Vigabatrin tablets (vigabatrin) dosage for adults: the maximum dosage is 2-3 grams per day. It is appropriate to start taking vigabatrin tablets (vigabatrin) at 1g a day, and then depending on the response after taking the medicine, if the response is good, it can be increased by 0.5g per week. Finally, the daily dosage is reached 2-3g. The maximum daily dosage of vigabatrin tablets (vigabatrin) should not exceed 3g. There is no inevitable connection between dosage and efficacy.
Vigabatrin should be used under the guidance of an epilepsy specialist or child neurologist. Reactions after taking the medication should be reported to the doctor promptly.
Vigabatrin is an oral medicine that can be taken once or twice a day, before or after meals. It is advisable to drink half a glass of water when taking this medicine. If you have taken this medicine for a sufficient period of time and your epilepsy does not improve, you should stop taking vigabatrin tablets. At this time, vigabatrin should be gradually stopped under the supervision of a doctor. Patients should note: Children younger than 6 years old are prone to choking when taking tablets, so attention should be paid to this.
The above is the introduction about (vigabatrin), I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.
Recommended related hot articles: /newsDetail/82940.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)